scispace - formally typeset
A

Aditya Sharma

Researcher at University of Virginia

Publications -  109
Citations -  2146

Aditya Sharma is an academic researcher from University of Virginia. The author has contributed to research in topics: Medicine & Fibromuscular dysplasia. The author has an hindex of 20, co-authored 79 publications receiving 1155 citations. Previous affiliations of Aditya Sharma include University of Virginia Health System & Cleveland Clinic.

Papers
More filters
Journal ArticleDOI

First International Consensus on the diagnosis and management of fibromuscular dysplasia.

TL;DR: This article is a comprehensive document on the diagnosis and management of fibromuscular dysplasia (FMD), which includes the first analysis of the European/International FMD Registry and provides updated data from the US Registry for FMD.
Journal ArticleDOI

Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD.

TL;DR: Patients with FMD have a high prevalence of aneurysm and/or dissection prior to or at the time of FMD diagnosis, and patients with dissection were more likely to experience ischemic events, and a significant number of patients withdissection or aneurYSm underwent therapeutic procedures for these vascular events.
Journal ArticleDOI

Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium

TL;DR: This consensus practice document provides a comprehensive review of the diagnosis, treatment, and follow-up of acute PE, including both clinical data and consensus opinion to provide guidance for clinicians caring for these patients.
Journal ArticleDOI

COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review.

TL;DR: The role of image-based AI is considered, which can be used to characterize the tissues of a COVID-19 patient and classify the severity of their infection, which is more important than ever as the pandemic surges and countries worldwide grapple with limited medical resources for detection and diagnosis.